2019 Financials

Statement of Financial Position

Assets Total 2019 Total 2018
Cash and Cash Equivalents $12,481,416 $13,299,317
Investments $10,857,778 $10,187,383
Contributions Receivable (Net) $19,744,931 $13,734,662
Prepaid Expenses and Other Assets $108,594 $51,403
TOTAL ASSETS $43,192,719 $37,272,765
Liabilities Total 2019 Total 2018
Accounts Payable $139,414 $65,314
Grants Payable (Net) $12,248,645 $17,294,177
Deferred Revenue $285,000 $280,000
Due to Affiliate $137,174 $109,159
TOTAL ASSETS $12,810,233 $17,748,650
Net Assets Total 2019 Total 2018
Unrestricted $17,045,668 $5,789,453
Temporarily Restricted $13,336,818 $13,734,662
TOTAL NET ASSETS $30,382,486 $19,524,115
TOTAL LIABILITIES AND NET ASSETS $43,192,719 $37,272,765

Statement of Activities

Revenue & Expense Statement
Revenue Total 2019 Total 2018
Contributions (Collectible Net) $2,562,352 $2,895,365
Special Events (Net) $18,753,320 $2,038,435
Sponsorship $490,000 $514,710
Interest/Investment $820,089 $114,094
In Kind Contributions $399,679 $0
Other Income $32,061
TOTAL ASSETS $23,057,501 $5,562,604
Expenses Total 2019 Total 2018
Research Grants $9,265,006 $13,525,762
Personnel Costs $1,592,119 $1,588,653
Travel & Entertainment $384,245 $350,487
Other Expenses $364,228 $354,131
Meetings & Conferences $253,609 $277,208
Professional Fees $171,928 $163,814
Occupancy $167,995 $144,917
TOTAL EXPENSES $12,199,130 $16,404,972
NET INCOME/(LOSS) $10,858,371 ($10,842,368)

Financial presentation based on MRA’s 2019 externally audited financials. Full audit and IRS 990 are available online at curemelanoma.org/about-mra/financials/

MRA Functional Expenses